Evrofarma SA

Athens Stock Exchange EVROF.AT

Evrofarma SA Revenue for the year ending December 31, 2023: USD 53.82 M

Evrofarma SA Revenue is USD 53.82 M for the year ending December 31, 2023, a 10.84% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Evrofarma SA Revenue for the year ending December 31, 2022 was USD 48.55 M, a 16.23% change year over year.
Evrofarma SA Revenue for the year ending December 31, 2021 was USD 41.78 M, a 0.85% change year over year.
Evrofarma SA Revenue for the year ending December 31, 2020 was USD 41.42 M, a 10.25% change year over year.
Evrofarma SA Revenue for the year ending December 31, 2019 was USD 37.57 M, a -0.47% change year over year.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

Athens Stock Exchange: EVROF.AT

Evrofarma SA

CEO	Mr. Paschalis H. Papazilakis
IPO Date	June 13, 2000
Location	Greece
Headquarters	1st km Didymoteicho – Orestiada
Employees	166
Sector	Consumer Staples
Industries Dairy & Milk

Description

Evrofarma SA produces and sells dairy products in Greece. It offers milk, yoghurt, cheese, and fermented beverages. The company also exports its products. Evrofarma SA was founded in 1991 and is headquartered in Didymoteicho, Greece.

Key trends

Past 5 years